Your browser doesn't support javascript.
loading
Recurrent Peripheral Stromal Keratitis Following Corneal Collagen Cross-linking: A Case Report.
Faramarzi, Amir; Hassanpour, Kiana; Roshandel, Danial; Fatourechi, Ali.
Afiliação
  • Faramarzi A; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hassanpour K; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Roshandel D; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Fatourechi A; Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Ophthalmic Vis Res ; 14(2): 211-214, 2019.
Article em En | MEDLINE | ID: mdl-31114658
PURPOSE: Corneal collagen cross-linking (CXL) has become the standard initial intervention in eyes with progressive keratoconus (KC) that have not undergone keratoplasty. The prolonged exposure of the de-epithelialized cornea predisposes it to adverse complications, such as microbial keratitis and melting. Herein, we report a case of bilateral recurrent peripheral stromal keratitis following CXL. CASE REPORT: We present a 29-year-old woman who complained of ocular redness and discomfort in both eyes for 4 months, and had undergone bilateral CXL 10 months before. The best spectacle corrected visual acuity (BSCVA) was 60/200 in the right and 80/200 in the left eye. Both eyes showed moderate conjunctival hyperemia, dilation, and engorgement of the perilimbal episcleral vessels. There was a peripheral corneal stromal infiltration with thinning, and an overlying epithelial defect in the right eye with a lucid interval from the limbus. She was treated with lubricating eye drops and ointments and topical corticosteroids every 4 hours for 2 weeks then slowly tapered off. Afterwards, she experienced multiple recurrences in both eyes, which were successfully managed with topical corticosteroids and lubricants. After 2 years, her BSCVA was 20/30 with -3.00-5.50 * 90 in the right eye and 20/40 with -4.00-4.50 * 90 in the left. CONCLUSION: Although CXL is a safe method, studies with longer follow-ups are needed to investigate the risk of rare complications.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article